Deferoxamine (CAS 70-51-9) is a highly effective chelating agent, primarily recognized for its ability to bind iron. Its structure allows it to form stable complexes with ferric (Fe3+) and ferrous (Fe2+) iron ions, facilitating their excretion from the body. This fundamental property makes it indispensable in clinical settings for treating conditions like iron overload, where excessive iron accumulation can lead to serious health issues.

Beyond its direct therapeutic applications, Deferoxamine is a critical compound for research and development in the pharmaceutical industry. Its capacity to modulate iron levels and its interaction with other biological pathways, such as up-regulating HIF-1α, make it a valuable tool for investigating diseases like cancer, neurodegenerative disorders, and even COVID-19. Researchers use Deferoxamine to study cellular mechanisms, explore new drug targets, and validate therapeutic hypotheses. For these scientific endeavors, obtaining high-purity Deferoxamine is essential for reliable and reproducible results.

When seeking to purchase Deferoxamine for research or manufacturing, it is crucial to identify dependable suppliers. As a leading manufacturer and supplier of pharmaceutical intermediates and fine chemicals, we offer Deferoxamine (CAS 70-51-9) that meets stringent quality specifications. Our competitive pricing and commitment to supply chain integrity ensure that scientists and manufacturers can consistently access this vital compound. We empower your research and production by providing a reliable source for this critical chelating agent, making it easier for you to buy the quality materials you need.